Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Sharifi

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
The Oncologist|March 7, 2009
Commentary: Antioxidants for cancer: new tricks for an old dog?Nima Sharifi
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 9, 2011
The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancerNima Sharifi
The Journal of Steroid Biochemistry and Molecular Biology|February 28, 2026
Serendipity, steroids and scienceNima Sharifi
Future Oncology (London, England)|November 3, 2011
Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancerNima Sharifi
Anti-Cancer Agents in Medicinal Chemistry|September 2, 2009
Hormonal therapy for prostate cancer: toward further unraveling of androgen receptor functionNima Sharifi
Molecular Endocrinology (Baltimore, Md.)|April 18, 2013
Minireview: Androgen metabolism in castration-resistant prostate cancerNima Sharifi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2020
Homozygous HSD3B1(1245C) inheritance and poor outcomes in metastatic castration-resistant prostate cancer with abiraterone or enzalutamide: what does it mean?Nima Sharifi
Expert Opinion on Investigational Drugs|June 8, 2010
New agents and strategies for the hormonal treatment of castration-resistant prostate cancerNima Sharifi
The New England Journal of Medicine|March 7, 2014
Steroid receptors aplenty in prostate cancerNima Sharifi
Nature Reviews. Urology|February 9, 2021
Kicking the dirt in the hunt for discoveries: pursuing a career in biomedical scienceNima Sharifi
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
The Oncologist|March 7, 2009
Commentary: Antioxidants for cancer: new tricks for an old dog?Nima Sharifi
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 9, 2011
The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancerNima Sharifi
The Journal of Steroid Biochemistry and Molecular Biology|February 28, 2026
Serendipity, steroids and scienceNima Sharifi
Future Oncology (London, England)|November 3, 2011
Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancerNima Sharifi
Anti-Cancer Agents in Medicinal Chemistry|September 2, 2009
Hormonal therapy for prostate cancer: toward further unraveling of androgen receptor functionNima Sharifi
Molecular Endocrinology (Baltimore, Md.)|April 18, 2013
Minireview: Androgen metabolism in castration-resistant prostate cancerNima Sharifi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2020
Homozygous HSD3B1(1245C) inheritance and poor outcomes in metastatic castration-resistant prostate cancer with abiraterone or enzalutamide: what does it mean?Nima Sharifi
Expert Opinion on Investigational Drugs|June 8, 2010
New agents and strategies for the hormonal treatment of castration-resistant prostate cancerNima Sharifi
The New England Journal of Medicine|March 7, 2014
Steroid receptors aplenty in prostate cancerNima Sharifi
Nature Reviews. Urology|February 9, 2021
Kicking the dirt in the hunt for discoveries: pursuing a career in biomedical scienceNima Sharifi
Pageof 17